(Q37673373)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20070787%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

review article

1 reference

title

Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20070787%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

Michael S Ritsner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20070787%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20070787%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20070787%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20070787%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20070787%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

32-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20070787%20AND%20SRC:MED&resulttype=core&format=json

Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures.

16 January 2020

cites work

1 reference

12 December 2020

Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage.

1 reference

12 December 2020

Dehydroepiandrosterone replacement in women with adrenal insufficiency.

1 reference

12 December 2020

Dehydroepiandrosterone protects hippocampal neurons against neurotoxin-induced cell death: mechanism of action

1 reference

12 December 2020

Dehydroepiandrosterone sulfate and psychiatric measures in a frail, elderly residential care population

1 reference

12 December 2020

Anti-stress effects of dehydroepiandrosterone: protection of rats against repeated immobilization stress-induced weight loss, glucocorticoid receptor production, and lipid peroxidation

1 reference

12 December 2020

Dehydroepiandrosterone prevents oxidative injury induced by transient ischemia/reperfusion in the brain of diabetic rats

1 reference

12 December 2020

Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity

1 reference

12 December 2020

Neuroactive steroid levels in patients with generalized anxiety disorder

1 reference

12 December 2020

Preclinical development of neurosteroids as neuroprotective agents for the treatment of neurodegenerative diseases

1 reference

12 December 2020

Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging

1 reference

12 December 2020

Study of the stress response: role of anxiety, cortisol and DHEAs

1 reference

12 December 2020

Dissecting human adrenal androgen production

1 reference

12 December 2020

Low pregnenolone sulphate plasma concentrations in patients with generalized social phobia

1 reference

12 December 2020

Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression

1 reference

12 December 2020

Clozapine decreases rat brain dehydroepiandrosterone and dehydroepiandrosterone sulfate levels

1 reference

12 December 2020

Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia

1 reference

12 December 2020

Neuroprotection by the steroids pregnenolone and dehydroepiandrosterone is mediated by the enzyme aromatase

1 reference

12 December 2020

Incipient neurovulnerability and neuroprotection in early psychosis

1 reference

12 December 2020

Chronic pregnenolone effects in normal humans: attenuation of benzodiazepine-induced sedation

1 reference

12 December 2020

The use of delta 5-pregnenolone in various clinical disorders

1 reference

12 December 2020

Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex

1 reference

12 December 2020

The neuroendocrinology of posttraumatic stress disorder: new directions

1 reference

12 December 2020

Dehydroepiandrosterone (DHEA) and its sulfate (DHEAS) inhibit the apoptosis in human peripheral blood lymphocytes

1 reference

12 December 2020

Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins

1 reference

12 December 2020

Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients

1 reference

12 December 2020

beta-estradiol, dehydroepiandrosterone, and dehydroepiandrosterone sulfate protect against N-methyl-D-aspartate-induced neurotoxicity in rat hippocampal neurons by different mechanisms

1 reference

12 December 2020

Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it.

1 reference

12 December 2020

Is there a receptor for dehydroepiandrosterone or dehydroepiandrosterone sulfate?

1 reference

12 December 2020

Cortisol/dehydroepiandrosterone ratio and responses to antipsychotic treatment in schizophrenia.

1 reference

12 December 2020

Neurosteroids: endogenous regulators of the GABA(A) receptor

1 reference

12 December 2020

Improvement of extrapyramidal symptoms following dehydroepiandrosterone (DHEA) administration in antipsychotic treated schizophrenia patients: a randomized, double-blind placebo controlled trial

1 reference

12 December 2020

Alterations in DHEA metabolism in schizophrenia: two-month case-control study

1 reference

12 December 2020

Blood DHEAS concentrations correlate with cognitive function in chronic schizophrenia patients: a pilot study

1 reference

12 December 2020

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

12 December 2020

Neurosteroids and cholinergic systems: implications for sleep and cognitive processes and potential role of age-related changes.

1 reference

12 December 2020

Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations

1 reference

12 December 2020

Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.

1 reference

12 December 2020

Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions.

1 reference

12 December 2020

State and trait related predictors of serum cortisol to DHEA(S) molar ratios and hormone concentrations in schizophrenia patients.

1 reference

12 December 2020

Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects.

1 reference

12 December 2020

Neurosteroids as endogenous inhibitors of neuronal cell apoptosis in aging

1 reference

12 December 2020

Analysis of clinical symptomatology, extrapyramidal symptoms and neurocognitive dysfunction following dehydroepiandrosterone (DHEA) administration in olanzapine treated schizophrenia patients: a randomized, double-blind placebo controlled trial.

1 reference

12 December 2020

Neurosteroid regulation of central nervous system development

1 reference

12 December 2020

Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats

1 reference

12 December 2020

Dehydroepiandrosterone sulfate levels are associated with more favorable cognitive function in women

1 reference

12 December 2020

Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanism of action and relevance to psychiatric disorders

1 reference

12 December 2020

Neurosteroids: biosynthesis, metabolism and function of pregnenolone and dehydroepiandrosterone in the brain.

1 reference

12 December 2020

Hormonal response to dehydroepiandrosterone administration in schizophrenia: findings from a randomized, double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology

1 reference

12 December 2020

Pregnenolone protects the PC-12 cell line against amyloid beta peptide toxicity but its sulfate ester does not.

1 reference

12 December 2020

Excitatory neurosteroids attenuate apoptotic and excitotoxic cell death in primary cortical neurons.

1 reference

12 December 2020

Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS).

1 reference

12 December 2020

Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia

1 reference

12 December 2020

Neurosteroid biosynthesis: enzymatic pathways and neuroendocrine regulation by neurotransmitters and neuropeptides

1 reference

12 December 2020

Neuroactive steroid regulation of neurotransmitter release in the CNS: action, mechanism and possible significance

1 reference

12 December 2020

Neurocognitive deficits in schizophrenia are associated with alterations in blood levels of neurosteroids: a multiple regression analysis of findings from a double-blind, randomized, placebo-controlled, crossover trial with DHEA.

1 reference

12 December 2020

Dehydroepiandrosterone and age-related cognitive decline

1 reference

12 December 2020

Neuroendocrine and immunological correlates of chronic stress in 'strictly healthy' populations.

1 reference

12 December 2020

Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial

1 reference

12 December 2020

Effects on industrial production of the administration of Delta5 pregnenolone to factory workers.

1 reference

12 December 2020

The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women

1 reference

12 December 2020

Effect of chronic hyperprolactinemia induced by sulpiride on plasma dehydroepiandrosterone (DHA) in normal men.

1 reference

12 December 2020

Dehydroepiandrosterone and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures.

1 reference

12 December 2020

Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensitivity in normal men.

1 reference

12 December 2020

Steroid effects on central neurons and implications for psychiatric and neurological disorders.

1 reference

12 December 2020

Neuronal actions of dehydroepiandrosterone. Possible roles in brain development, aging, memory, and affect

1 reference

12 December 2020

Human dehydroepiandrosterone sulfotransferase. Purification, molecular cloning, and characterization.

1 reference

12 December 2020

Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEA-S) in Alzheimer's disease and in cerebrovascular dementia.

1 reference

12 December 2020

Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors.

1 reference

12 December 2020

The neurosteroid pregnenolone sulfate blocks deficits induced by a competitive NMDA antagonist in active avoidance and lever-press learning tasks in mice.

1 reference

12 December 2020

Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans

1 reference

12 December 2020

The neuropsychopharmacological potential of neuroactive steroids

1 reference

12 December 2020

Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity

1 reference

12 December 2020

Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development

1 reference

12 December 2020

Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression

1 reference

12 December 2020

Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial

1 reference

12 December 2020

The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women

1 reference

12 December 2020

Neurosteroids: a novel function of the brain.

1 reference

12 December 2020

Dehydroepiandrosterone: biosynthesis and metabolism in the brain

1 reference

12 December 2020

10.1111/J.1755-5949.2009.00118.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20070787%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20070787%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference